Five years ago, we told you about a venture capital auction wherein dozens of VCs donated their time toward a greater good — helping fund research at the Leukemia & Lymphoma Society, one of
Y Combinator unveiled one of its most impressive startup batches to date yesterday, featuring big ideas in medicine, finance, and marketplaces. After carefully watching the demos, speaking with founde
Matt de Silva was working as a hedge fund manager with Thiel Capital in the fall of 2013 when he got the news that his dad had brain cancer -- specifically, a Glioblastoma Multiforme (GBM), which is a